Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway

Pharmaceutical Research

Volumn 21, Issue 4, 2004, Pages 661-670

  Jeong, Woo Sik ^a   Kim, In Wha ^a   Hu, Rong ^a   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Natural chemopreventive agents; Nuclear factor kappa B (NF B); Transcription regulation

Indexed keywords

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM SALT; ALLYL ISOTHIOCYANATE; CASPASE; CASPASE 3; CHEMOPREVENTIVE AGENT; CURCUMIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOTHIOCYANIC ACID DERIVATIVE; LIPOPOLYSACCHARIDE; LUCIFERASE; NATURAL PRODUCT; PHENETHYL ISOTHIOCYANATE; PROCYANIDIN; PROCYANIDIN B1; PROCYANIDIN B2; RESVERATROL; SULFORAPHANE; TRYPAN BLUE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN HT29; CELL VIABILITY; COLON CANCER; COLORIMETRY; CONTROLLED STUDY; CURCUMA LONGA; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME KINETICS; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MODULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RED WINE; SIGNAL TRANSDUCTION; SPICE; TEA; VEGETABLE; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HT29 CELLS; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 1842555356     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000022413.43212.cf     Document Type: Article

References (52)

1. D. M. Parkin, P. Pisani, and J. Ferlay. Global cancer statistics. CA Cancer J. Clin. 49:33-64 (1999).
2. D. K. Rex. Screening for colon cancer and evaluation of chemoprevention with coxibs. J. Pain Symptom Manage. 23:S41-S50 (2002).
3. P. A. Baeuerle and D. Baltimore. NF-kappa B: ten years after. Cell 87:13-20 (1996).
4. A. M. Kamat and D. L. Lamm. Chemoprevention of urological cancer. J. Urol. 161:1748-1760 (1999).
5. J. D. Potter. Colon cancer - do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story? J. Nutr. 123:418-423 (1993).
6. U. Siebenlist, G. Franzoso, and K. Brown. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-455 (1994).
7. S. Ghosh, M. J. May, and E. B. Kopp. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260 (1998).
8. J. M. Muller, H. W. Ziegler-Heitbrock, and P. A. Baeuerle. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187:233-256 (1993).
9. M. Karin and Y. Ben-Neriah. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663 (2000).
10. Y. Yamamoto and R. B. Gaynor. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135-142 (2001).
11. X. H. Li, X. Fang, and R. B. Gaynor. Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex. J. Biol. Chem. 276:4494-4500 (2001).
12. S. Amit and Y. Ben-Neriah. NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin. Cancer Biol. 13:15-28 (2003).
13. P. J. Barnes and M. Karin. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071 (1997).
14. V. R. Baichwal and P. A. Baeuerle. Activate NF-kappa B or die? Curr. Biol. 7:R94-R96 (1997).
15. A. N. Kong, R. Yu, V. Hebbar, C. Chen, E. Owuor, R. Hu, R. Ee, and S. Mandlekar. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480-481:231-241 (2001).
16. S. Gupta, N. H. Purcell, A. Lin, and S. Sen. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J. Cell Biol. 159:1019-1028 (2002).
17. N. H. Purcell, G. Tang, C. Yu, F. Mercurio, J. A. DiDonato, and A. Lin. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 98:6668-6673 (2001).
18. J. W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096-21103 (1997).
19. N. A. Thornberry and Y. Lazebnik. Caspases: enemies within. Science 281:1312-1316 (1998).
20. G. Guhr and P. A. Lachance. Role of phytochemicals in chronic disease prevention. In P. A. Lachance (ed.), Designer Foods III. Garlic, Soy and Licorice., Food & Nutrition Press, Trumbull. 1997, pp. 311-357.
21. T. A. Shapiro, J. W. Fahey, K. L. Wade, K. K. Stephenson, and P. Talalay. Human metabolism and excretion of cancer chemoprotective glucosinolates and isoihiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev. 7:1091-1100 (1998).
22. E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhauser. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:32008-32015 (2001).
23. E. J. Patten and M. J. DeLong. Temporal effects of the detoxification enzyme inducer, benzyl isothiocyanate: activation of c-Jun N-terminal kinase prior to the transcription factors AP-1 and NFkappaB. Biochem. Biophys. Res. Commun. 257:149-155 (1999).
24. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:813-819 (1991).
25. A. Kumar, S. Dhawan, N. J. Hardegen, and B. B. Aggarwal. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem. Pharmacol. 55:775-783 (1998).
26. S. Singh and B. B. Aggarwal. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270:24995-25000 (1995).
27. S. S. Han, Y. S. Keum, H. J. Seo, and Y. J. Surh. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. Biochem. Mol. Biol. 35:337-342 (2002).
28. C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163:3474-3483 (1999).
29. S. M. Plummer, K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18:6013-6020 (1999).
30. S. Philip and G. C. Kundu. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha / IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278:14487-14497 (2003).
31. S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62:4945-4954 (2002).
32. D. I. Cho, N. Y. Koo, W. J. Chung, T. S. Kim, S. Y. Ryu, S. Y. Im, and K. M. Kim. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action. Life Sci. 71:2071-2082 (2002).
33. X. Gao, Y. X. Xu, N. Janakiraman, R. A. Chapman, and S. C. Gautam. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 62:1299-1308 (2001).
34. S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:6509-6519 (2000).
35. S. H. Tsai, S. Y. Lin-Shiau, and J. K. Lin. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126:673-680 (1999).
36. C. S. Yang, P. Maliakal, and X. Meng. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42:25-54 (2002).
37. Y. C. Park, G. Rimbach, C. Saliou, G. Valacchi, and L. Packer. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett. 465:93-97 (2000).
38. C. Saliou, G. Rimbach, H. Moini, L. McLaughlin, S. Hosseini, J. Lee, R. R. Watson, and L. Packer. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic. Biol. Med. 30:154-160 (2001).
39. G. Y. Yang, J. Liao, K. Kim, E. J. Yurkow, and C. S. Yang. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19:611-616 (1998).
40. H. Kamata, T. Manabe, S. Oka, K. Kamata, and H. Hirata. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 519:231-237 (2002).
41. H. Nakagawa, M. Wachi, J. T. Woo, M. Kato, S. Kasai, F. Takahashi, I. S. Lee, and K. Nagai. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem. Biophys. Res. Commun. 292:94-101 (2002).
42. J. Li, H. Zhou, Q. Cai, and G. Xiao. Activation of NF-kappaB and apoptosis of intestinal epithelial cells induced by hydrogen peroxide. Chin. J. Traumatol. 5:209-213 (2002).
43. C. Chen, G. Shen, V. Hebbar, R. Hu, E. D. Owuor, and A. N. Kong. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24:1369-1378 (2003).
44. A. Simon, D. P. Allais, J. L. Duroux, J. P. Basly, S. Durand-Fontanier, and C. Delage. Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett. 129:111-116 (1998).
45. H. Ahsan, N. Parveen, N. U. Khan, and S. M. Hadi. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem. Biol. Interact. 121:161-175 (1999).
46. M. Salucci, L. A. Stivala, G. Maiani, R. Bugianesi, and V. Vannini. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br. J. Cancer 86:1645-1651 (2002).
47. S. M. Kuo. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110:41-48 (1996).
48. S. K. Manna, A. Mukhopadhyay, N. T. Van, and B. B. Aggarwal. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 163:6800-6809 (1999).
49. S. Simizu, M. Takada, K. Umezawa, and M. Imoto. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J. Biol. Chem. 273:26900-26907 (1998).
50. H. S. Samaha, G. J. Kelloff, V. Steele, C. V. Rao, and B. S. Reddy. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res. 57:1301-1305 (1997).
51. R. Yu, S. Mandlekar, K. J. Harvey, D. S. Ucker, and A. N. Kong. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58:402-408 (1998).
52. R. Hu, B. R. Kim, C. Chen, V. Hebbar, and A. N. Kong. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24:1361-1367 (2003).